- All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells
-
Kim Y, Jeung HK, Cheong JW, Song J, Bae SH, Lee JI, Min YH
- KMID: 2505376
- Yonsei Med J.
- 2020 Sep;61(9):762-773.
- doi: 10.3349/ymj.2020.61.9.762
Purpose: Pharmacological inhibition of mutant isocitrate dehydrogenase (IDH) reduces R-2-hydroxyglutarate (2-HG) levels and restores cellular differentiation in vivo and in vitro. The IDH2 inhibitor enasidenib (AG-221) has been approved by... -
- CITED
-
- Close
- SHARE
-
- Close
- HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
-
Park H, Kim DY, Kim SJ, Chung H, Cho H, Jang JE, Cheong JW, Min YH, Song JW, Kim JS
- KMID: 2424785
- Cancer Res Treat.
- 2018 Oct;50(4):1121-1129.
- doi: 10.4143/crt.2017.329
PURPOSE: Although hepatitis B surface antigen (HBsAg)–negative, hepatitis B core antibody (anti-HBc)–negative patients are not considered to be at risk for hepatitis B virus (HBV)–related hepatitis, the actual risk remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
-
Byun HK, Yoon HI, Cho J, Kim HJ, Min YH, Lyu CJ, Cheong JW, Kim JS, Kim HS, Kim SJ, Yang AJ, Lee BM, Lee WH, Lee J, Ahn KJ, Suh CO
- KMID: 2393556
- Radiat Oncol J.
- 2017 Sep;35(3):257-267.
- doi: 10.3857/roj.2017.00290
PURPOSE: Pulmonary toxicities, including infectious pneumonia (IP) and idiopathic pneumonia syndrome (IPS), are serious side effects of total body irradiation (TBI) used for myeloablative conditioning. This study aimed to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
-
Lee JY, Chung H, Cho H, Jang JE, Kim Y, Kim SJ, Kim JS, Hyun SY, Min YH, Cheong JW
- KMID: 2390980
- Blood Res.
- 2017 Sep;52(3):184-192.
- doi: 10.5045/br.2017.52.3.184
BACKGROUND: Isolated myeloid sarcoma (MS) is a rare extramedullary tumor mass composed of malignant myeloid precursor cells without any evidence of leukemia in the peripheral blood and bone marrow. We... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Significance of Implementing Concurrent Direct Antiglobulin Test and Antibody Elution Test in Diagnosing Hemolytic Disease of the Fetus and Newborn
-
Nah H, Lee E, Song J, Cheong JW, Kim HO
- KMID: 2401741
- Korean J Blood Transfus.
- 2017 Dec;28(3):238-247.
- doi: 10.17945/kjbt.2017.28.3.238
BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is a condition in which immune hemolytic anemia occurs in fetuses or newborns as a result of maternal alloimunized antibodies transfer.... -
- CITED
-
- Close
- SHARE
-
- Close
- Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
-
Park H, Chung H, Lee J, Jang J, Kim Y, Kim SJ, Kim JS, Min YH, Cheong JW
- KMID: 2374186
- Yonsei Med J.
- 2017 Jan;58(1):35-42.
- doi: 10.3349/ymj.2017.58.1.35
PURPOSE: Decitabine, a DNA hypomethylating agent, was recently approved for use in Korea for older adults with acute myeloid leukemia (AML) who are not candidates for standard chemotherapy. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion
-
Ha J, Cheong JW, Shin S, Lee ST, Choi JR
- KMID: 2373546
- Ann Lab Med.
- 2016 May;36(3):287-289.
- doi: 10.3343/alm.2016.36.3.287
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
-
Hyun SY, Han SH, Kim SJ, Jang JE, Kim Y, Cho H, Lee JY, Cheong JW, Min YH, Song JW, Kim JS
- KMID: 2363688
- J Korean Med Sci.
- 2016 Apr;31(4):510-518.
- doi: 10.3346/jkms.2016.31.4.510
The aim of this study was to identify the risk factors associated with severe bacterial infection (SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens. A total of... -
- CITED
-
- Close
- SHARE
-
- Close
- Multiple Meningocerebral Metastasis and Extensive Skull Metastasis from Squamous Cell Carcinoma of Esophagus: A Case Report and Review of Literature
-
Na MK, Kim CH, Kim JM, Cheong JW, Ryu JI, Kim HW
- KMID: 2356985
- Brain Tumor Res Treat.
- 2016 Oct;4(2):142-144.
- doi: 10.14791/btrt.2016.4.2.142
Esophageal carcinoma rarely metastasizes to the brain. Although some studies have mentioned esophageal cancer with solitary brain metastasis or with meningocerebral metastasis or with skull metastasis, multiple meningocerebral metastasis and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation
-
Lee HG, Kim SY, Kim I, Kim YK, Kim JA, Kim YS, Lee HS, Park J, Kim SJ, Shim H, Eom HS, Park BB, Lee J, Park SK, Cheong JW, Park KW
- KMID: 2172759
- Blood Res.
- 2015 Sep;50(3):160-166.
- doi: 10.5045/br.2015.50.3.160
BACKGROUND: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine,... -
- CITED
-
- Close
- SHARE
-
- Close
- Fatal PTLD Accompanied by Rapid Lymphocyte Proliferation in the Early Phase of Allogeneic HSCT
-
Lee JY, Kim G, Lee E, Park SH, Kim JS, Cheong JW, Min YH
- KMID: 2269038
- Korean J Med.
- 2015 Aug;89(2):243-248.
- doi: 10.3904/kjm.2015.89.2.243
Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of clinically and morphologically heterogeneous lymphoid proliferations of various clonal compositions that are observed after hematopoietic stem cell transplantation (HSCT) or solid organ... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of the Effectiveness of the Heavy-Light Chain Quantitative Test
-
Kim JH, Choi WJ, Lee M, Shin HW, Cheong JW, Kim JW
- KMID: 1821779
- Lab Med Online.
- 2015 Jul;5(3):127-132.
- doi: 10.3343/lmo.2015.5.3.127
BACKGROUND: The heavy-light chain (HLC) quantitative test can identify and quantify the heavy and light chains of each immunoglobulin class. The purpose of this study was to evaluate the effectiveness... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Guidelines for Treating Chronic Myelogenous Leukemia - The Korean Society of Hematology Chronic Myelogenous Leukemia Working Party
-
Kim DY, Lee JO, Kim KH, Kim BS, Kim SH, Kim YK, Kim HJ, Kim I, Park S, Park JS, Chung JS, Cheong JW, Jung CW, Jo DY, Sohn SK, Chronic Myelogenous Leukemia Working Party, the Korean Society of Hematology
- KMID: 2269125
- Korean J Med.
- 2015 Apr;88(4):406-419.
- doi: 10.3904/kjm.2015.88.4.406
BACKGROUND/AIMS: The first edition of the Korean treatment guidelines for chronic myelogenous leukemia (CML) was published in 2006. We intend to update those guidelines to include the use of next-generation... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemophagocytic Lymphohistiocytosis after Lung Transplantation
-
Leem AY, Moon SW, Kim SY, Park MS, Kim YS, Kim SK, Chang J, Paik HC, Cheong JW, Chung KS
- KMID: 2227700
- Korean J Crit Care Med.
- 2015 Feb;30(1):38-41.
- doi: 10.4266/kjccm.2015.30.1.38
Hemophagocytic lymphohistiocytosis (HLH) is a rare but fatal complication after solid organ transplantation. Acquired forms of HLH are described in association with severe sepsis, autoimmune disorders, malignancy, immune-compromised states, infections,... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
-
Choi SH, Cho J, Kim JS, Cheong JW, Suh CO
- KMID: 2144293
- Radiat Oncol J.
- 2015 Dec;33(4):310-319.
- doi: 10.3857/roj.2015.33.4.310
PURPOSE: Follicular lymphoma (FL) is an indolent non-Hodgkin's lymphoma that is highly sensitive to radiotherapy (RT). However, the effectiveness of RT has not been well established. We reviewed our experiences... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Antimicrobial Therapy: Efficacy and Safety for Methicillin-Resistant Staphylococcus aureus Infections and Its Impact on the Length of Hospital Stay
-
Yoon YK, Kim ES, Hur J, Lee S, Kim SW, Cheong JW, Choo EJ, Kim HB
- KMID: 2284974
- Infect Chemother.
- 2014 Sep;46(3):172-181.
- doi: 10.3947/ic.2014.46.3.172
BACKGROUND: Carefully switching from intravenous to oral antibiotic therapy has shown to reduce treatment costs and lengths of hospital stay as well as increase safety and comfort in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma
-
Lee HG, Choi Y, Kim SY, Kim I, Kim YK, Kim YS, Lee HS, Kim SJ, Kim JA, Park BB, Park J, Shim H, Eom HS, Lee J, Park SK, Cheong JW, Park KW
- KMID: 2172806
- Blood Res.
- 2014 Jun;49(2):107-114.
- doi: 10.5045/br.2014.49.2.107
BACKGROUND: We investigated factors that influence outcomes in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab combined with the CHOP regimen (R-CHOP) followed by upfront autologous stem cell transplantation... -
- CITED
-
- Close
- SHARE
-
- Close
- The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen
-
Kim Y, Kim SJ, Hwang D, Jang J, Hyun SY, Kim YR, Kim JS, Min YH, Cheong JW
- KMID: 2070204
- Yonsei Med J.
- 2014 Nov;55(6):1568-1575.
- doi: 10.3349/ymj.2014.55.6.1568
PURPOSE: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of... -
- CITED
-
- Close
- SHARE
-
- Close
- Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
-
Kim SJ, Cheong JW, Min YH, Choi YJ, Lee DG, Lee JH, Yang DH, Lee SM, Kim SH, Kim YS, Kwak JY, Park J, Kim JY, Kim HG, Kim BS, Ryoo HM, Jang JH, Kim MK, Kang HJ, Cho IS, Mun YC, Jo DY, Kim HY, Park BB, Kim JS
- KMID: 1796916
- J Korean Med Sci.
- 2014 Jan;29(1):61-68.
- doi: 10.3346/jkms.2014.29.1.61
We assessed the success rate of empirical antifungal therapy with itraconazole and evaluated risk factors for predicting the failure of empirical antifungal therapy. A multicenter, prospective, observational study was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea
-
Kim JS, Cheong JW, Shin HJ, Lee JW, Lee JH, Yang DH, Lee WS, Kim H, Park JS, Kim SH, Kim YS, Kwak JY, Chae YS, Park J, Do YR, Min YH
- KMID: 1779880
- Yonsei Med J.
- 2014 Jan;55(1):9-18.
- doi: 10.3349/ymj.2014.55.1.9
PURPOSE: To identify prognostic factors for the outcomes of empirical antifungal therapy, we performed a multicenter, prospective, observational study in immunocompromised patients with hematological malignancies. MATERIALS AND METHODS: Three hundred seventy-six... -
- CITED
-
- Close
- SHARE
-
- Close
